Big news. But we won't hear much if and when the appeal modifies this judgment to Monsanto's favor.
This could be the perfect time to buy Bayer stock.
Oops, too late:
The Latest $80 Million Cancer Judgment Is Just the Beginning of Roundup’s Woes
Bayer’s share price has plunged 25 percent over the past two weeks.
Tom Philpott March 29, 2019 6:00 AM